Ignite Creation Date:
2025-12-24 @ 5:58 PM
Ignite Modification Date:
2025-12-24 @ 5:58 PM
Study NCT ID:
NCT06536868
Status:
RECRUITING
Last Update Posted:
2024-08-05
First Post:
2024-07-31
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Tislelizumab Combined With Chemotherapy and Thoracic Radiotherapy in ES-SCLC
Sponsor:
Second Hospital of Shanxi Medical University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-08-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2026-07-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2024-07-31
First Submit QC Date:
None
Study First Post Date:
2024-08-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-31
Last Update Post Date:
2024-08-05
Last Update Post Date Type:
ACTUAL